Taysha Gene Therapies (TSHA) PT Raised to $6 at Truist Securities, "data places TSHA as the leader"
Tweet Send to a Friend
(Updated - August 15, 2023 1:50 AM EDT)
Truist Securities analyst Joon Lee raised the price target on Taysha ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Truist Securities analyst Joon Lee raised the price target on Taysha ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
